lifestyle.capitolhilltimes.com

Author: NEUROPHET

Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer’s Disease Therapies

March 26, 2026
Neurophet Secures FDA 510(k) Clearance for “Neurophet AQUA AD Plus,” Marking Its Third U.S. Regulatory Milestone

February 11, 2026
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore

December 9, 2025
Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of ‘Neurophet AQUA AD’

December 6, 2025
Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business — To Accelerate U.S. Market

December 2, 2025
Neurophet and The Florey Strengthen Research Collaboration on ‘Neurophet AQUA’ to Advance Alzheimer’s Disease Diagnosis

November 25, 2025